Inhalant abuse

Pediatrics

Volumn 119, Issue 5, 2007, Pages 1009-1017

  Williams, Janet F ^a   Storck, Michael ^a   Joffe, Alain ^a   Behnke, Marylou ^a   Knight, John R ^a   Kokotailo, Patricia K ^a   Sims, Tammy ^a   Brenneman, George ^a   Agarwal, Indu ^a   Bell, Joseph T ^a   Biggs, Vincent M ^a   Etzel, Ruth ^a   Hoffman, Benjamin ^a   Jarvis, James N ^a  

^a NONE

Author keywords

Drug abuse; Inhalant abuse; Inhalants; Inhaled nitrites; Solvent abuse; Substance abuse

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; BUTANE; CHLOROETHANE; CHLOROFLUOROCARBON; DICHLOROMETHANE; ENFLURANE; ETHER; HALOTHANE; HEXANE; HYDROCARBON; NITRITE; NITROUS OXIDE; PROPANE; SILDENAFIL; TETRACHLOROETHYLENE; THINNER; TOLUENE; VOLATILE AGENT;

APLASTIC ANEMIA; ARTICLE; BRAIN DISEASE; CARDIOMYOPATHY; CEREBELLAR ATAXIA; CLINICAL FEATURE; CRANIAL NEUROPATHY; DRUG INTOXICATION; GEOGRAPHIC DISTRIBUTION; HUMAN; INHALANT ABUSE; KIDNEY TUBULE NECROSIS; LEUKEMIA; LIVER CELL CARCINOMA; METHEMOGLOBINEMIA; MORBIDITY; MORTALITY; NEPHRITIS; NEPHROSIS; OPTIC NERVE DISEASE; PARKINSONISM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SNIFFING; SUBSTANCE ABUSE; TOXICOKINETICS; WITHDRAWAL SYNDROME;

ADMINISTRATION, INHALATION; ADOLESCENT; ANESTHETICS, INHALATION; CHILD; HUMANS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 34248186531     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0470     Document Type: Article

References (66)

1. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend. 1998;51:207-214
2. Beauvais F, Oetting ER. Toward a clear definition of inhalant abuse. Int J Addict. 1987;22:779-784
3. Romanelli F, Smith KM, Thornton AC, Pomeroy C. Poppers: epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy. 2004;24:69-78
4. Wu L, Pilowsky DJ, Schlenger WE. Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry. 2004;43:1206-1214
5. Neumark YD, Delva J, Anthony JC. The epidemiology of adolescent inhalant drug involvement. Arch Pediatr Adolesc Med. 1998;152:781-786
6. Edwards RW, Oetting ER. Inhalant use in the United States. In: Kozel N, Sloboda Z, DeLaRosa M, eds. Epidemiology of Inhalant Abuse: An International Perspective. Rockville, MD: National Institute on Drug Abuse 1995:8-28Publication No. NIH 95-3831
7. Spear S, Longshore D, McCaffrey D, Ellickson P. Prevalance of substance use among white and American Indian young adolescents in a Northern Plains state. J Psychoactive Drugs. 2005;37:1-6
8. Beauvais F, Wayman JC, Jumper-Thurman P, Plested B, Helm H. Inhalant abuse among American Indian, Mexican American, and non-Latino white adolescents. Am J Drug Alcohol Abuse. 2002;28:171-187
9. Spiller HA. Epidemiology of volatile substance abuse (VSA) cases reported to US poison centers. Am J Drug Alcohol Abuse. 2004;30:155-165
10. Substance Abuse and Mental Health Services Administration. Results From the 2005 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration Office of Applied Studies; 2006. Publication No. SMA 06-4194. Available at: http://oas.samhsa.gov. Accessed December 7, 2006
11. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Teen drug use continues down in 2006, particularly among older teens; but use of prescription-type drugs remains high [press release]. 2006. Available at: www.monitoringthefuture.org/pressreleases/06drugpr.pdf. Accessed January 18, 2007
12. Center for Substance Abuse Research. U.S. residents more likely than Canadians to use inhalants, cocaine, and stimulants; slightly less likely to use marijuana. 2005. Available at: www.cesar.umd.edu/cesar/cesarfax/vol14/14-46. pdf. Accessed April 18, 2006
13. Substance Abuse and Mental Health Services Administration, Office of Applied Studies; RTI International. Inhalant use and delinquent behaviors among young adolescents. Available at: www.oas.samhsa.gov/2k5/inhale/inhale.htm. Accessed April 18, 2006
14. Swaim RC, Beauvais F, Chavez EL, Oetting ER. The effect of school dropout rates on estimates of adolescent substance use among three racial/ethnic groups. Am J Public Health. 1997;87:51-55
15. Beauvais F, Chavez EL, Oetting ER, Deffenbacher JL, Cornell GR. Drug use, violence, and victimization among white American, Mexican American and American Indian dropouts, students with academic problems and students in good standing. J Couns Psychol. 1996;43:292-299
16. McGarvey EL, Clavet GJ, Mason W, Waite D. Adolescent inhalant abuse: environments of use. Am J Drug Alcohol Abuse. 1999;25:731-741
17. Howard MO, Jenson JM. Inhalant use among antisocial youth: prevalence and correlates. Addict Behav. 1999;24:59-74
18. Grunbaum JA, Kann L, Kinchen SA, et al. Youth risk behavior surveillance: National Alternative High School Youth Risk Behavior Survey, United States, 1998. MMWR CDC Surveill Summ. 1999;48(7):1-44
19. Howard MO, Walker RD, Walker PS, Cottler LB, Compton WM. Inhalant use among urban American Indian youth. Addiction. 1999;94:83-95
20. Mackesy-Amiti ME, Fendrich M. Inhalant use and delinquent behavior among adolescents: a comparison of inhalant users and other drug users. Addiction. 1999;94:555-564
21. Sakai JT, Hall SK, Mikulich-Gilbertson SK, Crowley TJ. Inhalant use, abuse, and dependence among adolescent patients: commonly comorbid problems. J Am Acad Child Adolesc Psychiatry. 2004;43:1080-1088
22. Beauvais F. Comparison of drug use rates for reservation Indian, non-reservation Indian and Anglo youth. Am Indian Alsk Native Ment Health Res. 1992;5(1):13-31
23. Zebrowski PL, Gregory RJ. Inhalant use patterns among Eskimo school children in western Alaska. J Addict Dis. 1996;15:67-77
24. Center for Substance Abuse Treatment. Inhalants. Subst Abuse Treat Advis. 2003;3(1):1-8
25. Feuillet L, Mallet S, Spadari M. Twin girls with neurocutaneous symptoms caused by mothball intoxication. N Engl J Med. 2006;355:423-424
26. Broussard LA. The role of the laboratory in detecting inhalant abuse. Clin Lab Sci. 2000;13:205-209
27. DeViore WJ. Dynamics of drinking hairspray-water mix[t]ure. "Ocean" Awareness Project. Available at: http://wellbriety-nci.org/ Publications/ocean.htm. Accessed April 18, 2006
28. Lorenc JD. Inhalant abuse in the pediatric population: a persistent challenge. Curr Opin Pediatr. 2003;15:204-209
29. Brouette T, Anton R. Clinical review of inhalants. Am J Addict. 2001;10:79-94
30. Ramsey J, Anderson HR, Bloor K, Flanagan RJ. An introduction to the practice, prevalence and chemical toxicology of volatile substance abuse. Hum Toxicol. 1989;8:261-269
31. Bass M. Sudden sniffing death. JAMA. 1970;212:2075-2079
32. Shepherd RT. Mechanism of sudden death associated with volatile substance abuse. Hum Toxicol. 1989;8:287-291
33. Field-Smith ME, Butland BK, Ramsey JD, Anderson HR. Trends in Death Associated With Abuse of Volatile Substances 1971-2003. Report 18. London, England: St George's, University of London, Division of Community Health Sciences; 2005. Available at: www.vsareport.org. Accessed April 18, 2006
34. Bowen SE, Daniel J, Balster RL. Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend. 1999;53:239-245
35. Maxwell JC. Deaths related to the inhalation of volatile substances in Texas: 1988-1998. Am J Drug Alcohol Abuse. 2001;27:689-697
36. Lolin Y. Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol. 1989;8:293-300
37. Meadows R, Verghese A. Medical complications of glue sniffing. South Med J. 1996;89:455-462
38. Maruff P, Burns CB, Tyler P, Currie BJ, Currie J. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain. 1998;121:1903-1917
39. Tenenbein M, deGroot W, Rajani KR. Peripheral neuropathy following intentional inhalation of naphtha fumes. Can Med Assoc J. 1984;131:1077-1079
40. Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol. 2002;40:21-34
41. Keane JR. Toluene optic neuropathy. Ann Neurol. 1978;4:390
42. Ehyai A, Freemon FR. Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry. 1983;46:349-351
43. Wiseman MN, Banim S. "Glue sniffer's" heart? Br Med J (Clin Res Ed). 1987;294:739
44. Kaplan HG, Bakken J, Quadracci L, Schubach W. Hepatitis caused by halothane sniffing. Ann Intern Med. 1979;90:797-798
45. Taher SM, Anderson RJ, McCartney R, Popovtzer MM, Schrier RW. Renal tubular acidosis associated with toluene "sniffing." N Engl J Med. 1974;290:765-768
46. Fischman CM, Oster JR. Toxic effects of toluene: a new cause of high anion gap metabolic acidosis. JAMA. 1979;241:1713-1715
47. Austin H, Delzell E, Cole P. Benzene and leukemia: a review of the literature and a risk assessment. Am J Epidemiol. 1988;127:419-439
48. Powars D. Aplastic anemia secondary to glue sniffing. N Engl J Med. 1965;273:700-702
49. Keriotis AA, Upadhyaya HP. Inhalant dependence and withdrawal symptoms. J Am Acad Child Adolesc Psychiatry. 2000;39:679-680
50. Pearson MA, Hoyme HE, Seaver LH, Rimsza ME. Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics. 1994;93:211-215
51. Arnold GL, Kirby RS, Langendoerfer S, Wilkins-Haug L. Toluene embryopathy: clinical delineation and developmental follow-up. Pediatrics. 1994;93:216-220
52. Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonatal Ed. 1996;74:F204-F207
53. Engstrand DA, England DM, Huntington RW III. Pathology of paint sniffers' lung. Am J Forensic Med Pathol. 1986;7:232-236
54. Dinwiddie SH, Reich T, Cloninger CR. The relationship of solvent use to other substance use. Am J Drug Alcohol Abuse. 1991;17:173-186
55. Young SJ, Longstaffe S, Tenenbein M. Inhalant abuse and the abuse of other drugs. Am J Drug Alcohol Abuse. 1999;25:371-375
56. Brandes JC, Bufill JA, Pisciotta AV. Amyl nitrite-induced hemolytic anemia. Am J Med. 1989;86:252-254
57. Meredith TJ, Ruprah M, Liddle A, Flannagan RJ. Diagnosis and treatment of acute poisoning with volatile substances. Hum Toxicol. 1989;8:277-286
58. Fregert S, Poulsen J, Trulsson L. Yellow stained skin from sodium nitrite in an etching agent. Contact Dermatitis. 1980;6:296
59. Kurbat RS, Pollack CV Jr. Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med. 1998;16:167-169
60. Akerman HE. The constitution of adhesives, and its relationship to solvent abuse. Hum Toxicol. 1982;1:223-230
61. Liss BI. Government, trade and industry and other preventive responses to volatile substance abuse. Hum Toxicol. 1989;8:327-330
62. Reidel S, Hebert T, Byrd P. Inhalant abuse: confronting the growing challenge. In: Treating Alcohol and Other Drug Abusers in Rural and Frontier Areas. Rockville, MD: Center for Substance Abuse Treatment; 1995. Technical assistance publication series #17. Available at: www.treatment.org/taps/tap17/ tap17toc.html. Accessed April 18, 2006
63. Jumper-Thurman P, Plested B, Beauvais F. Treatment strategies for volatile solvent abusers in the United States. In: Kozel N, Sloboda Z, DeLaRosa M, eds. Epidemiology of Inhalant Abuse: An International Perspective. Rockville, MD: National Institute on Drug Abuse 1995:250-259Publication No. NIH 95-3831
64. Beauvais F, Jumper-Thurman P, Plested B, Helm H. A survey of attitudes among drug user treatment providers toward the treatment of inhalant users. Substance Use Misuse. 2002;37:1391-1410
65. Thurman PJ, Green VA. American Indian adolescent inhalant use. Am Indian Alsk Native Ment Health Res. 1997;8(1):24-40
66. Kulig JW; American Academy of Pediatrics, Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics. 2005;115:816-821